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Review
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Epigenetic regulation of memory: implications 
in human cognitive disorders
Abstract: Epigenetic modification of chromatin struc-
ture is an important mechanism in the regulation of gene 
expression. Recent studies have shown that dynamic reg-
ulation of chromatin structure occurs in response to neu-
ronal stimulation associated with learning and memory. 
Learning-induced chromatin modifications include DNA 
methylation, histone acetylation, histone phosphorylation 
and histone methylation. Studies in animal models have 
used genetic and pharmacological methods to manipu-
late the epigenetic machinery in the brain during learning 
and memory formation. In general, these studies suggest 
that epigenetic regulation of chromatin structure is essen-
tial for long term memory (LTM) consolidation, which is 
known to require new gene transcription. Analysis of ani-
mal models has also implicated epigenetic mechanisms 
in impaired cognition associated with aging, neurodegen-
erative disease, and intellectual disability (ID). Recently, it 
has been shown that a subset of ID disorders and autism 
are caused by disruption of specific chromatin modifi-
cation complexes that are involved in nuclear hormone 
receptor mediated transcriptional regulation. This review 
provides an overview of chromatin modifications that are 
implicated in learning and memory and discusses the role 
of chromatin modifying proteins in learning-induced tran-
scriptional regulation and human cognitive disorders.
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Introduction
The cellular and molecular basis of learning and memory is 
a topic that has fascinated neuroscientists for decades. The 
sheer complexity of how we interpret, remember, and forget 
our experiences seems impossible to understand at the cel-
lular and molecular level. Yet, through the use of many dif-
ferent learning and memory paradigms in different model 
organisms, we are beginning to have a basic understand-
ing of the molecular changes that allow neurons to create 
and store memories (1, 2). Much of the work discussed here 
involves contextual fear conditioning in rodents (mice and 
rats) as a model for hippocampus-dependent associative 
memory (1), but studies using spatial learning (3), novel 
object recognition (4), and conditioned courtship behav-
ior in Drosophila (5), are also cited. Although there may be 
different mechanisms at work in different brain regions for 
different learning tasks, this review attempts to generalize 
the different learning paradigms according to their similari-
ties. Most learning paradigms do follow a general pattern 
consisting of a ‘training’ period, followed by ‘testing’ for 
a behavioral read-out at different time points after train-
ing. Although there is no standard definition of the differ-
ent phases of memory, it is commonly accepted that long 
term memory (LTM), ranging from 1 day to several months, 
requires gene transcription, while short term memory 
(STM), usually immediately after or within a few hours of 
training, does not.
Some of the signaling pathways that allow neurons 
to acquire and store memories have been deduced using 
genetic or pharmacological manipulations at different 
time points during and after training (1, 2). At the molecu-
lar level, memory acquisition seems to be initiated when 
post-synaptic NMDA-type receptors (NMDAR) are acti-
vated, leading to an influx of Ca2+ into the neuron (Figure 
1). Increased Ca2+ leads to the activation of kinases, like 
the Ca2+/calmodulin-dependent protein kinase II (CaMKII) 
(6). CaMKII kinase activity contributes to STM formation, 
through relatively fast acting mechanisms, such as phos-
phorylation of AMPA-type receptors (AMPAR), resulting 
in an increased localization of AMPAR in the postsynap-
tic membrane and strengthening of the activated synapse 
(1, 2, 6) (Figure 1). Over time, this newly acquired memory 
is consolidated into LTM, in a process that is depend-
ent on gene transcription. This learning-induced gene 
transcription is in part, regulated through Ca2+-activated 
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signaling mechanisms, including CaMK signaling, cyclic 
AMP (cAMP) signaling, and extracellular signal related 
kinase (ERK) signaling (1, 2, 7) (Figure 1). These pathways 
converge on the cAMP response element binding protein 
(CREB), a transcription factor that regulates many target 
genes in the formation of LTM (8). Although CREB is the 
best characterized transcription factor involved in the 
regulation of LTM, it is not the only transcription factor 
that responds to cellular signaling pathways activated by 
learning (7). In general, very little is known about the full 
extent of transcriptional regulation that is required for 
memory formation, or about CREB-independent mecha-
nisms in LTM. It is clear, however, that diverse forms of 
epigenetic regulation are essential in this process (9, 
10) (Figure 1). This review highlights work performed in 
model organisms over the last decade that makes signifi-
cant progress in uncovering the role of epigenetic regu-
lators and chromatin modifications in various types of 
learning and memory. The importance of these processes 
in human cognitive function is also discussed by examin-
ing recent literature implicating epigenetic regulation in 
the occurrence of autism and intellectual disability (ID), 
which is a cognitive disorder that is present in 1–3% of the 
population and is defined by low IQ ( < 70) and an early age 
of onset ( < 18 years).
Epigenetic modification of 
chromatin structure
The term epigenetics (‘above genetics’) was initially 
coined by C.H. Waddington in his effort to explain how 
cells containing identical genetic information can be so 
diverse in form and function (11). It is now known that 
development and cellular differentiation are dependent 
on epigenetic mechanisms for the maintenance of gene 
expression profiles and it is hypothesized that each cell 
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Figure 1 Signaling pathways and chromatin modifications in learning, memory, and human cognition.
Synaptic activity induced stimulation of NMDA-type receptors (NMDAR) leads to an influx of calcium ions (Ca2+) into the neuron. Ca2+ 
activated signaling pathways influence short-term memory by promoting recruitment of AMPA-type receptors (AMPAR) to the post-synaptic 
membrane. Ca2+ mediated signaling pathways also influence gene transcription by inducing epigenetic modifications. Several nuclear 
receptors are also associated with learning and memory processes including the glucocorticoid receptor, which is activated in response 
to stress. Chromatin modifications depicted here include a subset that is associated with learning and memory processes and/or human 
cognitive disorders.
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type may have a distinct gene expression profile that 
contributes to its characteristic features (12). Epigen-
etic modifications allow for heritability of chromatin 
structure and maintenance of gene expression patterns 
through many generations in dividing cells. Chromatin 
is made up of DNA and histone proteins. Histone pro-
teins H2a, H2b, H3, and H4 form an octamer, which is 
wrapped by 146 base pairs of DNA to form a nucleosome. 
Epigenetic modifications can alter chromatin structure 
to produce densely packed ‘repressive’ chromatin or 
loosely packed ‘active’ chromatin. Three important 
types of epigenetic modification that are pertinent to 
this review include: (1) DNA methylation; (2) post-trans-
lational modification of histone proteins; and (3) ATP-
dependent chromatin remodeling. A comprehensive 
overview of different epigenetic modifications and their 
effects on the chromatin environment and transcription 
has been reviewed elsewhere (13–15). Specific types of 
epigenetic modification that have been directly impli-
cated in learning and memory are discussed below. 
These include DNA methylation, histone acetylation, 
histone phosphorylation, and histone methylation 
(Figure 1).
DNA methylation and the 
formation of long term and 
distant memories
DNA methylation is catalyzed by DNA methyltrans-
ferases (DNMTs) and occurs on cytosine bases of CpG 
dinucleo tides. CpG dinucleotides are enriched at gene 
promoters in so-called ‘CpG islands’ and methylation 
of these CpG rich regions can repress transcription by 
directly limiting access of transcription factors to pro-
moters and/or by promoting the recruitment of methyl 
CpG-binding proteins (MeCP), which can in turn recruit 
larger repressive complexes (16). DNA methylation also 
occurs outside promoters regions and although the 
function of non-promoter DNA methylation is not well 
understood, it has been associated with transcriptional 
activation (17, 18). Furthermore, MeCP2 has been shown 
to recruit both activators and repressors of transcription 
(19), suggesting that DNA methylation can serve diverse 
roles in different contexts. DNA methylation appears to 
play a role in human cognitive function, since mutations 
affecting the methylation machinery (DNMT3b) and pro-
teins that bind to methylated DNA (MeCP2), have been 
shown to cause ID (20, 21). Defects in DNA methylation 
are also thought to play a role in neurodegeneration 
in Alzheimer’s disease, due to Alzheimer’s-associated 
defects in the metabolism of methyl-donor molecules 
(22–24).
DNA methylation has traditionally been viewed as 
a stable epigenetic mark, however, many recent studies 
have shown that DNA methylation is plastically regu-
lated, especially in neurons (25–27). Neuronal activation 
in mouse dentate granule neurons induces dynamic 
remodeling of genomic DNA methylation profiles, with 
methylation changes occurring largely outside of CpG 
islands in association with brain specific genes (27). 
Although the effect of these methylation changes on 
gene expression is not known, this work shows that 
DNA methylation is plastically regulated in response 
to neuronal activity. DNA methylation is also altered 
in the rat hippocampus in response to contextual fear 
conditioning and induction of long-term synaptic poten-
tiation (LTP) (25,  26, 28), a form of synaptic plasticity 
associated with memory (29). Accordingly, knock-out 
of components of the methylation machinery (Dnmt1 
and Dnmt3a) in mice and pharmacological inhibition of 
DNMTs in the rat hippocampus, results in defects in fear 
conditioned LTM and hippocampal LTP (25, 26, 28, 30). 
Dnmt3a expression is increased in the rat hippocampus 
in response to fear conditioning and pharmacological 
activation of ERK signaling, an important molecular 
pathway in memory consolidation (25, 28). This sug-
gests that learning-induced alterations in DNA meth-
ylation may result from learning-induced alterations in 
expression of the methylation machinery. Although ERK 
signaling has been implicated in this process, it is still 
unclear precisely how learning-induced neuronal plas-
ticity leads to DNMT activation and altered DNA meth-
ylation (Figure 1).
Changes in hippocampal DNA methylation in response 
to synaptic activity or learning, are relatively short-lived, 
lasting in the order of hours or days (25, 27, 31), yet contex-
tual fear memory in rats can last for many months. This 
long lasting remote memory is thought to reside in the pre-
frontal cortex and it was recently shown that pharmaco-
logical inhibition of DNMTs in this brain region, 1 month 
after fear conditioning, eliminated the ability to recall 
remote memories (31). Thus, DNA methylation in certain 
brain regions seems to act as a long lasting trace of distant 
memories. This is supported by the demonstration that 
DNA methylation in an adult rat brain is influenced by the 
amount of licking and grooming that the mother rat per-
forms during the first weeks of life (32). DNA methylation 
is also altered in post-mortem brains of suicide victims 
that had reported childhood abuse, suggesting that it also 
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influences long-term behavioral effects of distant experi-
ences in humans (33).
Histone modifications in learning 
and memory
Histone acetylation
Histone acetylation in the genome is regulated through a 
balance between histone acetyltransferases (HATs), which 
add acetyl groups, and histone deacetylases (HDACs), 
which remove them. Acetylation can occur at many differ-
ent lysine residues in the N-terminal tails of histone pro-
teins and this acetylation is usually associated with active 
transcription. It has been proposed that negatively charged 
acetyl groups disrupt DNA-histone interactions and loosen 
chromatin structure to allow for active gene transcrip-
tion (34), however, acetylated histone residues may also 
provide very specific binding platforms for components of 
the transcriptional machinery and epigenetic regulatory 
complexes, such as the switch/sucrose non-fermentable 
(SWI/SNF) ATPase complex (35). Disruption of the histone 
acetylation machinery through mutations in genes encod-
ing either HATs [CREB binding protein (CBP) and p300] or 
HDACs (HDAC4) causes ID in humans (36–38).
Many studies suggest that the interplay between 
HATs and HDACs is critical for LTM. Histone H3 acetyla-
tion increases in the rat hippocampus in response to 
contextual fear conditioning. This induction seems to be 
important for memory consolidation and is dependent 
on known memory related signaling components, such 
as NMDAR and ERK signaling (39, 40). ERK signaling 
can affect histone acetylation through direct activation 
of CREB, a transcription factor that is critical for LTM for-
mation (8). Activated CREB affects acetylation of specific 
target genes by recruitment of CBP, a HAT that is mutated 
in Rubinstein Taybi syndrome, an ID disorder (36). In 
mice, heterozygous mutations in CBP cause LTM defects 
in an object recognition assay (41, 42), which were rescued 
by pharmacological activation of CREB (43). The require-
ment of CBP in object recognition LTM is dependent on 
its ability to bind to CREB and on its HAT activity (44, 45), 
suggesting that CBP regulates LTM by acetylating  histones 
at CREB target genes. In addition, the expression level of 
CBP, p300 (a CBP paralog), and the p300/CBP-associated 
factor (PCAF), was shown to be increased during spatial 
memory consolidation in rats. This increased expression of 
the acetylation machinery was associated with increased 
H2B and H4 acetylation in the rat hippocampus and was 
shown to be defective in a hippocampal denervation 
model for Alzheimer’s disease that is defective in spatial 
memory consolidation (46). These studies have revealed 
a specific signaling pathway, which regulates memory, in 
part, by induction of histone acetylation (Figure 1).
Many studies have shown that promoting histone 
acetylation in the brain can improve memory. HDAC inhibi-
tors (HDACi) increase histone acetylation by inhibition of 
the molecular machinery responsible for removing acetyl 
groups from histone proteins. Treatment of rats and mice 
with HDACi can improve memory in wild type animals in 
several learning paradigms, including contextual and cued 
fear conditioning (40, 47–53). Furthermore, mice with dele-
tion of the Hdac2 gene showed enhanced LTM, in response 
to fear conditioning, while overexpression of Hdac2 in the 
mouse brain decreased LTM (47). Several other studies 
have also indicated that limiting HDAC2 levels is critical 
for optimal cognitive ability during aging (54–56). HDAC2 
was found to be elevated in Alzheimer’s disease brains and 
in mouse models for neurodegenerative disease, which 
have defects in spatial memory and fear conditioning 
(54). Reducing Hdac2 expression in these mouse models 
by short hairpin RNA (shRNA) knockdown fully abolished 
neurodegeneration-associated defects in fear condition-
ing and spatial memory, further supporting the idea that 
increased expression of HDACs is an important mechanism 
contributing to cognitive decline in neurodegenerative 
disease (54). In a mouse model for age dependent cognitive 
decline, aged mice with cognitive defects did not exhibit the 
normal pattern of increased histone acetylation and altered 
gene expression in response to fear conditioning, and these 
age-dependent molecular defects were also rescued by 
HDACi treatment (57). Furthermore, HDACi treatment has 
been shown to rescue LTM and LTP defects in many other 
rodent models for neurodegenerative disease, age depend-
ent cognitive decline, and ID (41, 55, 58–61). Taken together, 
these studies suggest that modulation of chromatin struc-
ture through histone acetylation is an important process 
in learning and memory and may be relevant to cognitive 
disorders, such as ID, neurodegenerative disease, and age 
dependent cognitive decline. The observation that HDACi 
treatment can improve cognitive function in wild type 
animals and in disease models with cognitive deficits, sug-
gests that manipulation of epigenetic pathways is a poten-
tial avenue for the treatment of cognitive dysfunction.
Histone phosphorylation
The role of histone phosphorylation in transcriptional 
regulation is not well understood, however, histones can 
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be phosphorylated at many residues and can play a role 
in diverse biological processes including chromosome 
condensation during cell division, DNA damage repair, 
and transcription (62). In studies involving learning and 
memory, phosphorylation of histone H3S10 is most com-
monly described and phosphorylation at this residue 
seems to be associated with transcriptional activation. 
H3S10 may affect transcription by directly altering chro-
matin structure, or through recruitment of other proteins 
and crosstalk with other epigenetic marks (62).
There are many parallels between histone phospho-
rylation and histone acetylation with respect to learning 
and memory. As with histone acetylation, H3S10 phos-
phorylation is increased in the hippocampus in response 
to fear conditioning in an ERK and mitogen and stress acti-
vated protein (MSK) dependent manner (39, 51). MSK is a 
histone kinase that is activated by ERK signaling (Figure 
1). Interestingly, decreasing histone phosphorylation 
through mutations in MSK causes defects in the spatial 
memory in mice, while enhancing histone phospho-
rylation by deletion of the histone phosphatase PP1 can 
improve spatial memory (63–65). Thus, in parallel with 
histone acetylation, increased histone phosphorylation 
appears to enhance memory formation.
Histone methylation
Histone methylation occurs on lysine and arginine resi-
dues and is regulated by histone methyltransferases 
(HMTs) and histone demethylases (HDMs). Methylation 
at different lysine residues within the N-terminal tails 
of histones can have different effects on gene transcrip-
tion; for example, H3K4 tri methylation is associated with 
active transcription, while H3K27 trimethylation is asso-
ciated with transcriptional repression (13, 15, 66). Meth-
ylated lysine residues can be present in either a mono-, 
di-, or tri-methylated state and the number of methylation 
groups at a particular residue can have different effects 
with respect to transcription. For example, H3K9 tri- and 
di-methylation are associated with repressive heterochro-
matin, while H3K9 mono-methylation is found at active 
genes (66). Many different mediators of histone meth-
ylation have been implicated in ID, including the HDMs, 
Jumonji/ARID domain-containing protein 1c (JARID1c) 
and PHD finger protein 8 (PHF8), and the HMTs, euchro-
matin histone methyltransferase 1 (EHMT1), nuclear 
receptor binding SET domain protein 1 (NSD1), mixed 
lineage leukemia 2 (MLL2), and MLL3, suggesting that 
these modifications can play a role in human cognitive 
function (67–73).
Like DNA methylation, histone acetylation, and 
histone phosphorylation, histone methylation is plasti-
cally regulated in the rat hippocampus, in response to 
contextual fear conditioning (52, 74). Histone H3 lysine 
4 trimethylation (H3K4me3), an activating modification, 
was found to be increased in the hippocampus 1 h after 
fear conditioning and returned to base line levels at 24 h 
after fear conditioning. Interestingly, heterozygous knock-
out mice, with loss of the H3K4-specific HMT Mll1, have 
defects in contextual fear conditioning (52) and heterozy-
gous mutations in the two human homologues, MLL2 and 
MLL3, cause ID (69, 73). Thus, H3K4me3 appears to be an 
important regulator of brain function in animal models 
and human disease.
Histone 3 lysine 9 dimethylation (H3K9me2), a 
repressive modification, is also regulated in the rat brain 
in response to contextual fear conditioning (52, 74). 
H3K9me2 increases in the hippocampus 1 h after con-
textual fear conditioning, however, this increase is also 
observed in response to context alone (52, 74). In con-
trast, in the entorhinal cortex (EC), H3K9me2 was specifi-
cally increased in response to fear conditioning and not 
context alone (74). At 24 h after contextual fear condition-
ing, H3K9me2 decreases in the hippocampus, but remains 
unchanged in the EC. Thus, H3K9me2 is dynamically 
regulated in different ways in different brain regions in 
response to fear conditioning. Accordingly, pharmaco-
logical inhibition of H3K9me2 in different brain regions 
has different effects on contextual fear conditioning; hip-
pocampal inhibition results in a loss of LTM, while EC 
inhibition results in increased LTM (74). These studies 
demonstrate a complex and dynamic role for H3K9me2 
in different regions of the rat brain during learning and 
memory formation.
In humans, heterozygous mutations in the EHMT1 
gene cause ID (68). EHMT1 and its paralog G9a form a 
complex that is important for H3K9me2 formation (75). In 
mice, heterozygous loss of Ehmt1 in whole animals and 
homozygous loss of Ehmt1 in the adult brain, causes a 
range of behavioral defects including reduced exploratory 
behavior and locomotion in response to a novel context 
(76, 77). Postnatal loss of Ehmt1 in excitatory neurons also 
caused defects in cued fear conditioning, sucrose prefer-
ence, and the behavioral response to caffeine (77). The fruit 
fly, Drosophila melanogaster, contains a single ortholog 
of G9a and EHMT1. Loss of Drosophila EHMT/G9a also 
causes several behavioral and cognitive defects, including 
altered larval locomotory behavior, loss of habituation, 
and defects in STM and LTM (78). These studies further 
underscore that H3K9 methylation is an important mecha-
nism in cognition and behavior (Figure 1).
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Targets of epigenetic control in 
learning and memory
Transcription is essential for LTM and several transcription 
factors, including CREB, CCAAT/enhancer binding protein 
(C/EBP), AP-1, and nuclear factor-kappa B (NF-κB), are 
known to play an important role in memory and memory 
associated synaptic plasticity (7). These transcription 
factors recruit epigenetic modifiers to their target genes, 
yet relatively little is known about the target genes and how 
they are regulated during learning and memory formation. 
Several studies have used a hypothesis-driven approach 
to identify targets of epigenetic regulation, focusing on 
genes that are known to be regulated by CREB signaling in 
response to neuronal activity or learning (47, 48, 54). One of 
the best characterized of these targets is the brain derived 
neurotrophic factor (BDNF), a small secreted protein that 
regulates synaptic activity by binding to TkrB receptors and 
activating downstream signaling pathways (80). BDNF is 
required in mice for normal LTP and has been implicated in 
memory acquisition and consolidation in the hippocampus 
and/or amygdala, using a variety of learning paradigms 
[for reviews of BDNF and its role in memory see (79–81)]. 
BDNF gene transcription is regulated in response to neu-
ronal activity and several studies suggest that this plastic-
ity is dependent on epigenetic factors. Induction of neuro-
nal depolarization in mouse embryonic cortical cultures 
resulted in increased BDNF expression, decreased DNA 
methylation within the BDNF promoter, and dissociation 
of a MeCP2-containing protein complex from the promoter 
(82). Expression of BDNF RNA is also induced in the rat hip-
pocampus in response to contextual fear conditioning and 
this change correlated with a loss of DNA methylation in the 
BDNF regulatory region (26). Interestingly, learning induced 
changes in BDNF promoter methylation and expression are 
dependent on functional NMDAR, showing that epigenetic 
alterations are induced by signaling pathways with a known 
role in learning and memory (26). In addition, alterations 
in histone methylation, and/or histone acetylation, have 
been observed in the BDNF regulatory region in response 
to contextual fear conditioning (26, 52, 83), spatial memory 
consolidation (46), and during age dependent cognitive 
decline (55). It has also been shown that HDAC2 can bind to 
the BDNF promoter and that knockout or overexpression of 
HDAC2 in neurons leads to decreased or increased histone 
acetylation at the BDNF promoter, respectively (47). Altered 
HDAC2 binding and histone acetylation in the BDNF pro-
moter was also observed in a mouse model for Alzheimer’s 
disease, suggesting that BDNF may be misregulated in neu-
rodegenerative disease (54).
Analysis of specific target genes has revealed the com-
plexity of epigenetic regulation in space and time during 
learning and memory. For example, the reelin gene shows 
altered patterns of epigenetic regulation in different brain 
regions. Contextual fear conditioning causes induced 
expression of reelin and reduced DNA methylation in its 
promoter in the hippocampus 1 h after training (25), while 
at the same time point, DNA methylation is increased in the 
reelin promoter in the cortex (31). The timing of epigenetic 
regulation can also vary from gene to gene. For example, 
reelin and other genes such as the memory suppressor, PP1 
(protein phosphatase 1), are transiently regulated during 
memory formation, showing altered epigenetic marks 1 h 
after fear conditioning, but not after 24 h (31). In contrast, 
other genes, such as the memory suppressor calcineurin, 
show a very stable regulation that begins 1 h after fear con-
ditioning and persists for many days (31). These studies 
reveal that epigenetic alterations occur at specific genes 
during learning and memory, but also underscore the com-
plexity of the brain, by demonstrating that specific genes 
are regulated in different ways in different brain regions 
at different time points during learning and memory 
formation.
Analysis of individual candidate target genes pro-
vides an excellent model for how genes may be regulated 
by epigenetic processes during learning and memory. 
However, these studies do not reveal the true mechanism 
or extent of gene regulation in learning and memory. 
Some studies have used a genome wide approach to 
determine how epigenetic regulators influence gene 
expression in the brain (30, 57, 64, 77, 78). Genome wide 
mRNA profiling has been performed in animals that 
have mutations in epigenetic regulators that are known 
to cause learning and memory defects. Some 200 genes 
were shown to be differentially expressed in the forebrain 
of mice with brain-specific mutations in PP1 (64). Inter-
estingly, several of the misregulated genes are known to 
be involved in learning and memory and/or had target 
consensus sequences for early growth response 1 (Egr1) 
and C/EBP, transcription factors known to be important 
for memory formation. This suggests that memory defects 
in PP1 mutant mice are due to transcriptional mis-regula-
tion of specific learning and memory pathways. In con-
trast, genome wide expression analysis in the forebrain 
of mice with mutations in Dnmt1 and Dnmt3a revealed 
upregulation of many genes involved in immunity (30). 
Interestingly, some of these immune genes can be directly 
linked to learning and memory processes, however, in 
general, these results would suggest that Dnmts are nor-
mally required for the suppression of these immune genes 
during steady state brain functioning. Analysis of gene 
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expression in different brain regions of mice with muta-
tions in the histone methyltransferases EHMT1/GLP and 
G9a revealed a similar scenario, where a few genes that 
are normally repressed in adult neurons were activated 
(77). This also suggested that learning and memory may 
be disrupted by inappropriate activation of genes in the 
brain. Genome wide analysis of EHMT/G9a target genes 
in a Drosophila model with cognitive defects, revealed 
enrichment for neuronal genes with known roles in 
learning and memory, suggesting that G9a does have the 
potential to target more specific learning and memory 
processes (78). However, it remains to be seen whether 
Drosophila EHMT/G9a target genes are misregulated in 
the brain during learning and memory.
In a study investigating age dependent cognitive 
decline, it was shown that hundreds of genes were differ-
entially expressed in the hippocampus of young mice in 
response to fear conditioning, while in older mice, with 
decreased cognitive ability, this differential regulation of 
gene expression in response to fear conditioning was lost 
(57). The lack of learning-induced differential gene expres-
sion in older animals was shown to be associated, in part, 
with alterations in histone H4K12 acetylation. Some of the 
differentially regulated genes reported by Peleg et al. (57), 
such as formin 2 (Fmn2), are known to be important for 
synaptic plasticity. However, this genome wide approach 
did not detect changes in some of the most studied plas-
ticity genes, like BDNF. This demonstrates the potential 
of genome-wide analysis, in contrast to candidate gene 
selection, for non-biased identification of novel learning 
and memory-regulated genes that are relevant to cogni-
tive phenotypes in animal models of human cognitive 
dysfunction.
Nuclear receptor signaling as 
an epigenetic mechanism in 
underlying human cognitive 
function
In several recent studies investigating genetic causes of ID 
and autism, mutations have been identified in epigenetic 
regulators with strong connections to nuclear hormone 
receptors (Figure 2). Nuclear receptors are a class of tran-
scription factor that is activated after binding to a ligand, 
often a hormone, which causes relocalization to the 
nucleus and rapid induction of gene expression. There are 
over 50 types of nuclear receptor identified in mammals 
and for most of these the activating ligand is unknown. 
Nuclear receptors rely on epigenetic modifications in 
order to optimally induce changes in gene expression 
(84). One common theme in nuclear receptor mediated 
transcriptional activation is the requirement for SWI/SNF 
ATPase chromatin remodeling, which serves to rearrange 
nucleosomes in order to optimize transcriptional activa-
tion (Figure 1) (84). Recently, mutations have been identi-
fied in many members of the SWI/SNF complex in indi-
viduals with Coffin Siris syndrome (CSS), a form of severe 
ID (Figure 2). In total, mutations in six SWI/SNF complex 
members including SWI/SNF related, matrix associated, 
actin dependent regulator of chromatin, subfamily B, 
member 1 (SMARCB1), SMARCA4, SMARCA2, SMARCE1, 
AT rich interactive domain 1A (ARID1A) and ARID1B, were 
identified in individuals with CSS (85, 86). Mutations in 
this complex are not exclusive to CSS, since mutations in 
SMARCA2, SMARCB1, and ARID1B have also been identi-
fied in other forms of syndromic ID and autism (73, 87–89) 
(Figure 2).
Mutations in nuclear receptor related chromatin 
modifiers were also identified in a group of individuals 
with Kleefstra syndrome phenotypic spectrum (KSS), a 
form of ID that is accompanied by childhood hypotonia 
and distinct facial features (73). Epigenetic regulators dis-
rupted in KSS individuals include the SWI/SNF member 
SMARCB1, the histone methyltransferase MLL3, and the 
nuclear receptor subfamily 1, group I, member 3 (NR1I3), 
also known as the constitutive androstane receptor 
(CAR) (73) (Figure 2). MLL3 tri methylates histone H3 at 
lysine 4 (H3K4me3) and is a critical member of the acti-
vating signal cointegrator-2 (ASC-2) complex (ASCOM), a 
large protein complex that is essential for transcriptional 
activation by many different nuclear receptors, includ-
ing NR1I3 (Figure 1) (90–96). MLL3 and SMARCB1 have 
been shown to interact directly, and this interaction is 
essential for the co-recruitment of ASCOM and SWI/SNF 
complexes to nuclear receptor target genes (92). The 
MLL3 paralog MLL2 is also involved in human cogni-
tion, since it was shown to be disrupted in yet another 
multisystem disorder with the presence of ID, Kabuki 
syndrome (69) (Figure 2). NR1I3 has not been studied 
in a neuronal context, however it is expressed in the 
brain (97, 98) and the Drosophila homolog, the ecdysone 
receptor (EcR), and has been shown to have a specific 
role in LTM (99). These studies suggest that the epige-
netic machinery surrounding nuclear receptor medi-
ated transcription is important in human cognition and 
disruption of this machinery can lead to different forms 
of ID. Interestingly, some of these same molecular com-
ponents, including ARID1B (SWI/SNF complex), MLL3, 
and the nuclear receptor subfamily 4, group A, member 
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Autism spectrum disorder
Coffin-Siris syndrome
Kabuki syndrome
Kleefstra syndrome
phenotypic spectrum
Nicolaides Baraitser
syndrome
Undefined ID disorders
ARID1B
ARID1A SMARCA2
SMARCA4
SMARCE1
SWI/SNF complex
(nucleosome remodeling)
ASCOM complex
(histone methylation)
SMARCB1MLL2 MLL3
NR4A2 NR1I3
Nuclear receptors
Figure 2 Nuclear receptor associated chromatin modification complexes in human cognitive disorders.
Members of the SWI/SNF complex the ASCOM complex and nuclear receptors that are implicated in human cognitive disorders (intellectual 
disability or autism) are indicated. A known direct protein-protein interaction between MLL3 and SMARCB1 is indicated (black line) (93). 
Paralogs are depicted as overlapping circles. Only complex members implicated in cognitive disorders are shown.
2 (NR4A2), have also been associated with autism (Figure 
2) (87).
Although the role of nuclear hormone receptor medi-
ated epigenetic modifications in learning and memory 
is still not well understood, it has long been known that 
hormones are important in regulating cognitive function. 
Glucocorticoid hormones are known to be essential for 
enhanced memory consolidation during stress (100). Glu-
cocorticoids are released in response to stress and act by 
binding the glucocorticoid receptor (GR), a classic nuclear 
receptor, which relies on SWI/SNF signaling and other epi-
genetic regulators to induce changes in gene transcription 
(Figure 1) (100). GR may also influence learning-mediated 
epigenetic changes, through its role in ERK/MSK signal-
ing (Figure 1). GR is required for LTM in the forced swim 
test, which is a stress-associated form of learning and 
memory requiring glucocorticoid activity in the dentate 
gyrus. GR was shown to bind directly to activated ERK and 
MSK in response to forced swimming and was required 
for increased MSK activation and downstream H3S10 
phosphorylation in response to forced swimming (101). 
Estrogen is also known to be involved in human cognition 
(102), and the orphan nuclear receptor NR4a is known to 
be induced during memory consolidation in mice, and 
members of this receptor family have been implicated 
in autism (87, 103). Future studies will reveal the extent 
to which different nuclear receptors are able to mediate 
alterations to the chromatin landscape during learning 
and memory.
Summary and future challenges
Over the last decade, it has become clear that epigen-
etic modification of chromatin structure is essential 
in the control of neuronal plasticity in learning and 
memory. Despite these advances, we are still far from 
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understanding how chromatin modifications help to 
shape neuronal circuits that encode memory. One of the 
challenges in addressing this issue is the fact that indi-
vidual memories are likely stored within a small subset 
of neurons, which make up only a fraction of those 
that are normally obtained for molecular analysis. This 
dilutes the relevant neurons, making it difficult to iden-
tify a molecular signature associated with learning and 
memory. In order to identify epigenetic changes that 
encode memory, we must first isolate the relevant neuro-
nal circuit in which that memory is stored. This presents 
a significant challenge both in obtaining the right mate-
rial at the right time, and in obtaining enough material 
for downstream molecular analysis. A second major chal-
lenge is to move from epigenetic analysis of specific can-
didate target genes, to analysis of the entire epigenome 
during the process of learning and memory. Genome-wide 
analysis of the epigenetic landscape during learning and 
memory may reveal novel mechanisms in learning and 
memory and provide a more comprehensive view of the 
molecular mechanisms underlying cognition. Finally, a 
refined understanding of epigenetic mechanisms in cog-
nition may help to conceptualize strategies for cognitive 
enhancement in individuals with cognitive disorders. 
This idea is reinforced by the use of HDAC inhibitors 
to improve cognition in animal models with cognitive 
defects. Thus, further analysis of epigenetic mechanisms 
at work in the nervous system will advance our knowl-
edge of basic neuroscience, and may contribute to the 
discovery of new treatments for cognitive disorders, such 
as ID, neurodegenerative diseases, age dependent cogni-
tive decline, and autism.
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